Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002168415 | SCV002425756 | likely benign | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002508053 | SCV002807710 | likely benign | Age related macular degeneration 9; Atypical hemolytic-uremic syndrome with C3 anomaly; Complement component 3 deficiency | 2021-11-19 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002168415 | SCV004146414 | likely benign | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing | C3: BP4, BP7 |
Prevention |
RCV003913768 | SCV004731059 | likely benign | C3-related disorder | 2019-06-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |